ACTA MEDICA MEDITERRANEA, vol.36, no.1, pp.731-736, 2020 (SCI-Expanded)
Introduction: The objective of our study is to compare the neuroprotective efficiency of Levetiracetam which is a new generation antiepileptic agent with Methyl prednisolone which is the single agent known to be used and be efficient in spinal cord damage today.